These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8639379)

  • 1. Antimetabolites.
    Johnston PG; Takimoto CH; Grem JL; Chabner BA; Allegra CJ; Chu E
    Cancer Chemother Biol Response Modif; 1996; 16():1-27. PubMed ID: 8639379
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer chemotherapy and biological response modifiers annual 16. Introduction.
    Pinedo HM; Longo DL; Chabner BA
    Cancer Chemother Biol Response Modif; 1996; 16():xvii-xviii. PubMed ID: 8639378
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimetabolites.
    Allegra CJ; Grem JL; Chu E; Johnston P; Yeh GC; Chabner BA
    Cancer Chemother Biol Response Modif; 1990; 11():1-28. PubMed ID: 2223392
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimetabolites.
    Chu E; Johnston PG; Takimoto CH; Politi PM; Grem JL; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1993; 14():1-25. PubMed ID: 8312100
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimetabolites.
    Allegra CJ; Baram J; Chabner BA; Yeh GC; Aiba K; Curt GA
    Cancer Chemother Biol Response Modif; 1987; 9():1-22. PubMed ID: 2484324
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimetabolites.
    Johnston PG; Takimoto CH; Grem JL; Fidias P; Grossbard ML; Chabner BA; Allegra CJ; Chu E
    Cancer Chemother Biol Response Modif; 1997; 17():1-39. PubMed ID: 9551206
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimetabolites.
    Chu E; Johnston PG; Grem JL; Takimoto CH; Van Groeningen C; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1994; 15():1-31. PubMed ID: 7779582
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimetabolites.
    Chu E; Grem JL; Johnston PG; Politi PM; Chabner BA; Allegra CJ
    Cancer Chemother Biol Response Modif; 1992; 13():1-30. PubMed ID: 1389906
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of apoptosis induction by nucleoside analogs.
    Sampath D; Rao VA; Plunkett W
    Oncogene; 2003 Dec; 22(56):9063-74. PubMed ID: 14663485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity.
    An Q; Robins P; Lindahl T; Barnes DE
    Cancer Res; 2007 Feb; 67(3):940-5. PubMed ID: 17283124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and mechanism of action of a duplex and multidrug of ethynylcytidine and 5-fluorodeoxyuridine.
    Bijnsdorp IV; Schwendener RA; Schott H; Schott S; Fichtner I; Honeywell RJ; Losekoot N; Laan AC; Peters GJ
    Nucleic Acids Symp Ser (Oxf); 2008; (52):651. PubMed ID: 18776548
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and antitumor activity of 5-fluorouracil derivatives.
    Ozaki S
    Med Res Rev; 1996 Jan; 16(1):51-86. PubMed ID: 8788214
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimetabolites.
    Schornagel JH
    Curr Opin Oncol; 1989 Dec; 1(2):179-85. PubMed ID: 2489957
    [No Abstract]   [Full Text] [Related]  

  • 14. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action.
    Azuma A; Matsuda A; Sasaki T; Fukushima M
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):609-19. PubMed ID: 11563078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimetabolites reduce the activities of enzymes with short half-lives in addition to inhibiting their specific targets.
    Weber G; Prajda N; Singhal RL
    Adv Exp Med Biol; 1994; 370():145-50. PubMed ID: 7660878
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Bowen D; Johnson DH; Southerland WM; Hughes DE; Hawkins M
    Anticancer Res; 1999; 19(2A):985-8. PubMed ID: 10368642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for non-homologous end-joining in the repair of UVA-induced DNA damage.
    Fell LJ; Paul ND; McMillan TJ
    Int J Radiat Biol; 2002 Nov; 78(11):1023-7. PubMed ID: 12456289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-induced senescence in human adenocarcinoma cells is accompanied by induction of p21(waf1/cip1) expression and lack of polyploidy.
    Dabrowska M; Mosieniak G; Skierski J; Sikora E; Rode W
    Cancer Lett; 2009 Oct; 284(1):95-101. PubMed ID: 19467772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFP fluorescence as an indicator of cancer cells response to methotrexate.
    Dabrowska M; Hendrikx PJ; Skierski J; Malinowska M; Bertino JR; Rode W
    Eur J Pharmacol; 2007 Jan; 555(2-3):93-9. PubMed ID: 17141212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
    Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.